Overview

Tailored Therapy for Helicobacter Pylori Rescue Treatment

Status:
Completed
Trial end date:
2018-07-31
Target enrollment:
Participant gender:
Summary
With increasing antibiotic resistance and unsatisfactory results of empiric eradication regimens, tailored therapy may be the best choice to achieve high efficacy for rescue treatment. This study aimed to evaluate the eradication rates, safety, and compliance of antimicrobial susceptibility-based tailored therapy for rescue treatment in patients with Helicobacter pylori infection.
Phase:
Phase 4
Details
Lead Sponsor:
Shanghai Jiao Tong University School of Medicine
Treatments:
Amoxicillin
Anti-Bacterial Agents
Anti-Infective Agents
Bismuth
Citric Acid
Clarithromycin
Esomeprazole
Levofloxacin
Metronidazole
Ofloxacin
Potassium Citrate